World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
72
Citations
16345
World Ranking
19888
National Ranking
633

Overview

Masakazu Yashiro is affiliated with Osaka Metropolitan University in Japan and has contributed extensively to research in medicine, with a strong focus on biochemistry, genetics, and molecular biology. Their work spans multiple subfields including oncology, molecular biology, pulmonary and respiratory medicine, cancer research, and surgery.

Their research topics prominently feature gastric cancer management and outcomes, cancer cells and metastasis, cholangiocarcinoma and gallbladder cancer studies, pancreatic and hepatic oncology research, cancer immunotherapy and biomarkers, cancer hypoxia and metabolism, and cancer genomics and diagnostics.

Frequent co-authors in their publications include Yurie Yamamoto, Masaichi Ohira, Atsushi Sugimoto, Sadaaki Nishimura, and Tomohiro Sera.

Yashiro publishes often in notable venues such as Cancer Research, Anticancer Research, PLoS ONE, International Journal of Molecular Sciences, and Cancer Science.

Recent papers include:

  • Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors, 2020, Cancer Research
  • Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing β1 Integrin, Enhancing Drug Resistance, 2020, Cancer Research
  • Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population, 2020, Developmental Cell
  • The heterogeneity of cancer-associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment, 2022, Cancer Science
  • Novel biomarkers for early detection of gastric cancer, 2023, World Journal of Gastroenterology

Best Publications

  • Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling

    Mitsunobu R. Kano;Younsoo Bae;Caname Iwata;Yasuyuki Morishita

  • Biomarkers of gastric cancer: Current topics and future perspective.

    Tasuku Matsuoka;Masakazu Yashiro

  • FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival.

    Kaiko Kunii;Lenora Davis;Julie Gorenstein;Harold Hatch

  • Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.

    Yoshitaka Hippo;Masakazu Yashiro;Masami Ishii;Hirokazu Taniguchi

  • Ulcerative colitis-associated colorectal cancer.

    Masakazu Yashiro

  • The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma

    Tasuku Matsuoka;Masakazu Yashiro

  • The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study

    Takahiro Toyokawa;Naoshi Kubo;Tatsuro Tamura;Katsunobu Sakurai

  • Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells

    Takatsugu Ishimoto;Takatsugu Ishimoto;Keisuke Miyake;Tannistha Nandi;Masakazu Yashiro

  • Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.

    Motohiko Tokuhisa;Yasushi Ichikawa;Nobuyoshi Kosaka;Takahiro Ochiya

  • Genetic pathways in the evolution of morphologically distinct colorectal neoplasms.

    M Yashiro;J M Carethers;L Laghi;K Saito

  • Role of the Stemness Factors Sox2, Oct3/4, and Nanog in Gastric Carcinoma

    Junko Matsuoka;Masakazu Yashiro;Katsunobu Sakurai;Naoshi Kubo

  • Prognostic Value of Microsatellite Instability in Resectable Pancreatic Cancer

    Bunzo Nakata;Yan Qing Wang;Masakazu Yashiro;Nobuaki Nishioka

  • Inhibition of Cyclooxygenase-2 Suppresses Lymph Node Metastasis via Reduction of Lymphangiogenesis

    Caname Iwata;Mitsunobu R. Kano;Akiyoshi Komuro;Masako Oka

  • Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks.

    Yu Kataoka;Toru Mukohara;Hideo Tomioka;Yohei Funakoshi

  • HER2 overexpression correlates with survival after curative resection of pancreatic cancer

    Masahiro Komoto;Bunzo Nakata;Ryosuke Amano;Nobuya Yamada

  • Predictive Potential of Preoperative Nutritional Status in Long-Term Outcome Projections for Patients with Gastric Cancer

    Katsunobu Sakurai;Masaichi Ohira;Tatsuro Tamura;Takahiro Toyokawa

  • Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice

    Masakazu Yashiro;Yong-Suk Chung;Shigehiko Nishimura;Tohru Inoue

  • Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors.

    Hiroshi Sootome;Hidenori Fujita;Kenjiro Ito;Hiroaki Ochiiwa

  • Epigenetic silencing of miR-210 increases the proliferation of gastric epithelium during chronic Helicobacter pylori infection

    Kotaro Kiga;Hitomi Mimuro;Masato Suzuki;Aya Shinozaki-Ushiku

  • Monoclonal Antibodies to Fibroblast Growth Factor Receptor 2 Effectively Inhibit Growth of Gastric Tumor Xenografts

    Wei-meng Zhao;Lihong Wang;Hangil Park;Sophea Chhim

Frequent Co-Authors

Kosei Hirakawa
Kosei Hirakawa Osaka Metropolitan University
Kohei Miyazono
Kohei Miyazono University of Tokyo
Wataru Yasui
Wataru Yasui Hiroshima University
Hideo Baba
Hideo Baba Kumamoto University
Hideki Yamaguchi
Hideki Yamaguchi Sasaki Institute
Yasuyuki Morishita
Yasuyuki Morishita University of Tokyo
Patrick Tan
Patrick Tan Duke NUS Graduate Medical School
Hiroyuki Aburatani
Hiroyuki Aburatani University of Tokyo
Kenneth Olden
Kenneth Olden National Institutes of Health
Toshikazu Ushijima
Toshikazu Ushijima National Cancer Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in medicine, several online degrees and pathways can complement your journey or offer alternative roles in healthcare. For those interested in healthcare leadership, a health care administration degree provides skills in managing clinics, hospitals, and health organizations, ideal for professionals aiming to shape the future of healthcare systems.

Current registered nurses who wish to advance their scope of practice can look into rn to np bridge programs. These programs allow RNs to earn a master's degree efficiently and become nurse practitioners, expanding both career and salary opportunities.

For those passionate about the science of nutrition and health promotion, pursuing a nutrition bachelor degree online is a flexible option. This path can lead to roles in public health, wellness coaching, or further studies in dietetics.

Aspiring healthcare executives can consider accredited online mha programs, which emphasize strategic management, healthcare policy, and leadership in the industry. All these options represent important avenues for those seeking impactful careers alongside—or beyond—traditional medical practice.

Best Scientists Citing Masakazu Yashiro

Trending Scientists

Recently Published Articles